$ARW
ARROW ELECTRONICS, INC.

2024 Q2 Form 10-Q Financial Statement

#000155837024006456 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $6.893B $6.924B
YoY Change -21.1%
Cost Of Revenue $6.046B $6.066B
YoY Change -20.68%
Gross Profit $846.4M $857.8M
YoY Change -24.01%
Gross Profit Margin 12.28% 12.39%
Selling, General & Admin $552.6M $583.3M
YoY Change -13.98%
% of Gross Profit 65.28% 68.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $41.04M $41.73M
YoY Change -12.09%
% of Gross Profit 4.85% 4.86%
Operating Expenses $552.6M $583.3M
YoY Change -13.98%
Operating Profit $212.3M $185.9M
YoY Change -49.72%
Interest Expense -$70.25M -$79.85M
YoY Change 1.19%
% of Operating Profit -33.09% -42.95%
Other Income/Expense, Net -$980.0K -$933.0K
YoY Change 14.89%
Pretax Income $139.4M $105.1M
YoY Change -60.39%
Income Tax $29.76M $22.04M
% Of Pretax Income 21.35% 20.96%
Net Earnings $108.7M $83.60M
YoY Change -60.29%
Net Earnings / Revenue 1.58% 1.21%
Basic Earnings Per Share $2.03 $1.54
Diluted Earnings Per Share $2.01 $1.53
COMMON SHARES
Basic Shares Outstanding 53.23M 53.81M
Diluted Shares Outstanding 54.18M 54.82M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $213.0M $242.8M
YoY Change 3.63%
Cash & Equivalents $213.0M $242.8M
Short-Term Investments
Other Short-Term Assets $1.011B $798.6M
YoY Change 110.77%
Inventory $4.655B $4.797B
Prepaid Expenses
Receivables $10.89B $11.06B
Other Receivables $0.00 $0.00
Total Short-Term Assets $16.77B $16.90B
YoY Change -0.6%
LONG-TERM ASSETS
Property, Plant & Equipment $499.7M $517.1M
YoY Change -13.76%
Goodwill $2.053B $2.055B
YoY Change 0.82%
Intangibles $112.5M $119.3M
YoY Change -25.63%
Long-Term Investments $60.40M $58.87M
YoY Change 1.2%
Other Assets $617.2M $612.0M
YoY Change 5.82%
Total Long-Term Assets $3.343B $3.362B
YoY Change -1.97%
TOTAL ASSETS
Total Short-Term Assets $16.77B $16.90B
Total Long-Term Assets $3.343B $3.362B
Total Assets $20.11B $20.26B
YoY Change -0.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.771B $8.940B
YoY Change -2.29%
Accrued Expenses $1.687B $1.475B
YoY Change 32.9%
Deferred Revenue
YoY Change
Short-Term Debt $11.32M $446.2M
YoY Change -92.15%
Long-Term Debt Due $849.2M $499.5M
YoY Change
Total Short-Term Liabilities $11.32B $11.36B
YoY Change 8.94%
LONG-TERM LIABILITIES
Long-Term Debt $2.479B $2.632B
YoY Change -33.33%
Other Long-Term Liabilities $495.7M $500.7M
YoY Change -12.6%
Total Long-Term Liabilities $2.975B $3.133B
YoY Change -30.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.32B $11.36B
Total Long-Term Liabilities $2.975B $3.133B
Total Liabilities $14.29B $14.49B
YoY Change -2.61%
SHAREHOLDERS EQUITY
Retained Earnings $5.983B $5.874B
YoY Change -36.95%
Common Stock $632.6M $623.1M
YoY Change -52.39%
Preferred Stock
YoY Change
Treasury Stock (at cost) $456.1M $405.7M
YoY Change -90.74%
Treasury Stock Shares
Shareholders Equity $5.743B $5.699B
YoY Change
Total Liabilities & Shareholders Equity $20.11B $20.26B
YoY Change -0.83%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $108.7M $83.60M
YoY Change -60.29%
Depreciation, Depletion And Amortization $41.04M $41.73M
YoY Change -12.09%
Cash From Operating Activities $320.2M $403.2M
YoY Change 43.06%
INVESTING ACTIVITIES
Capital Expenditures $22.10M $29.54M
YoY Change 9.88%
Acquisitions
YoY Change
Other Investing Activities $1.313M $5.139M
YoY Change -87.92%
Cash From Investing Activities -$20.79M -$24.40M
YoY Change 124.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -317.2M -317.7M
YoY Change 50.38%
NET CHANGE
Cash From Operating Activities 320.2M 403.2M
Cash From Investing Activities -20.79M -24.40M
Cash From Financing Activities -317.2M -317.7M
Net Change In Cash -17.85M 24.76M
YoY Change -162.34%
FREE CASH FLOW
Cash From Operating Activities $320.2M $403.2M
Capital Expenditures $22.10M $29.54M
Free Cash Flow $298.1M $373.7M
YoY Change 46.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000007536
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
ARROW ELECTRONICS, INC.
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-30
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
1-4482
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-1806155
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9151 East Panorama Circle
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Centennial
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2024Q1 dei City Area Code
CityAreaCode
303
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
824-4000
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $1 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
ARW
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53229856
CY2024Q1 us-gaap Revenues
Revenues
6924260000
CY2023Q2 us-gaap Revenues
Revenues
8736428000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
6066434000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
7622606000
CY2024Q1 us-gaap Gross Profit
GrossProfit
857826000
CY2023Q2 us-gaap Gross Profit
GrossProfit
1113822000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
583326000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
642431000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41727000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46679000
CY2024Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
46856000
CY2023Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2560000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
671909000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
691670000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
185917000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
422152000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-344000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-80000
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
98000
CY2023Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
10311000
CY2024Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
933000
CY2023Q2 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
853000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-79604000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-79658000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
105134000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
351872000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22036000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76547000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
83098000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
275325000
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-503000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1575000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
83601000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
273750000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.66
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.60
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54251000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58731000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54815000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59479000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
83098000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-99275000
CY2024Q1 us-gaap Translation Adjustment For Net Investment Hedge Net Of Tax Period Increase Decrease
TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease
3598000
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
529000
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
91000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-95239000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12141000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1651000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10490000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242810000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218053000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11062608000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12238073000
CY2024Q1 us-gaap Inventory Net
InventoryNet
4797053000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5187225000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
798591000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
684126000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
16901062000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
18327477000
CY2024Q1 us-gaap Land
Land
5691000
CY2023Q4 us-gaap Land
Land
5691000
CY2024Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
196291000
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
195579000
CY2024Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1624409000
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1632606000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1826391000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1833876000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1309303000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1303136000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
517088000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
530740000
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
58868000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
62741000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
119274000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
127440000
CY2024Q1 us-gaap Goodwill
Goodwill
2054536000
CY2023Q4 us-gaap Goodwill
Goodwill
2050426000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
612048000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
627344000
CY2024Q1 us-gaap Assets
Assets
20262876000
CY2023Q4 us-gaap Assets
Assets
21726168000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8940313000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10070015000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1474605000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1463915000
CY2024Q1 us-gaap Debt Current
DebtCurrent
945698000
CY2023Q4 us-gaap Debt Current
DebtCurrent
1653954000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11360616000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13187884000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2632250000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2153553000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
500672000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
507424000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57955000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57691000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
57955000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
57691000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
565166000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553340000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4725000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3880000
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
405663000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
297745000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5873818000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5790217000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-392130000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-298039000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5699146000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5805464000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
70192000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
71843000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5769338000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5877307000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20262876000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21726168000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
83098000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
275325000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41727000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46679000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13447000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
19497000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-344000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-80000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2801000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7530000
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-13000
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
10311000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1189000
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1321000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1057676000
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1701889000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-362813000
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
199521000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1077786000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1504701000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21053000
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-132316000
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
97563000
CY2023Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-33392000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
403210000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
223804000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29535000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20114000
CY2024Q1 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
5139000
CY2023Q2 us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
10867000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24396000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9247000
CY2024Q1 arw Proceeds From Repayment Of Short Term Debt
ProceedsFromRepaymentOfShortTermDebt
-709675000
CY2023Q2 arw Proceeds From Repayment Of Short Term Debt
ProceedsFromRepaymentOfShortTermDebt
-146050000
CY2024Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
477032000
CY2023Q2 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
34360000
CY2024Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0
CY2023Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
498600000
CY2024Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0
CY2023Q2 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-300000000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2929000
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5934000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
87948000
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
303801000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-317662000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-210957000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-36395000
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25039000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24757000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28639000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218053000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176915000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242810000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205554000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5877307000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
83098000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-95239000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13447000
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
2929000
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
112204000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5769338000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5611353000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
275325000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6871000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19497000
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
5934000
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
318800000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5600180000
CY2024Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The accompanying consolidated financial statements of Arrow Electronics, Inc. (the “company”) were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and reflect all adjustments of a normal recurring nature, which are, in the opinion of management, necessary for a fair presentation of the consolidated financial position and results of operations at, and for the periods presented. The consolidated results of operations for the interim periods are not necessarily indicative of results for the full year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">These consolidated financial statements do not include all of the information or notes necessary for a complete presentation and, accordingly, should be read in conjunction with the company’s audited consolidated financial statements and accompanying notes for the year ended December 31, 2023, as filed in the company’s Annual Report on Form 10-K.</p>
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1600000000
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The company operates on a quarterly calendar that closes on the Saturday closest to the end of the calendar quarter, except for the fourth quarter, which closes on December 31, 2024.</p>
CY2024Q1 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior period amounts were reclassified to conform to the current period presentation. These reclassifications did not have a material impact on previously reported amounts.</p>
CY2023Q4 us-gaap Goodwill
Goodwill
2050426000
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
17275000
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-13165000
CY2024Q1 us-gaap Goodwill
Goodwill
2054536000
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1600000000
CY2024Q1 arw Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
330622000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
211348000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
119274000
CY2023Q4 arw Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
332148000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
204708000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
127440000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7500000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8000000.0
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
58868000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
62741000
CY2024Q1 arw Equity In Earnings Of Affiliated Companies
EquityInEarningsOfAffiliatedCompanies
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:30.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quarter Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">April 1, </b></p></td></tr><tr><td style="vertical-align:bottom;width:67.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(thousands)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Marubun/Arrow</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"> (534)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"> (397)</p></td></tr><tr><td style="vertical-align:bottom;width:67.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 317</p></td></tr><tr><td style="vertical-align:bottom;width:67.05%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"> (344)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt;"> (80)</p></td></tr></table>
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-344000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-80000
CY2023Q4 arw Equity Method Investment Pro Rata Share Of Debt Obligations Of Joint Venture
EquityMethodInvestmentProRataShareOfDebtObligationsOfJointVenture
0
CY2024Q1 arw Equity Method Investment Pro Rata Share Of Debt Obligations Of Joint Venture
EquityMethodInvestmentProRataShareOfDebtObligationsOfJointVenture
0
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11207057000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
12384553000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
144449000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
146480000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11062608000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12238073000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
146480000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
93397000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2879000
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14991000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-861000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
388000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4049000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5083000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
144449000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
103693000
CY2024Q1 arw Agreement Amount With Purchaser To Transfer Financial Assets Accounted For As Sales
AgreementAmountWithPurchaserToTransferFinancialAssetsAccountedForAsSales
600000000.0
CY2024Q1 us-gaap Accounts Receivable Sale
AccountsReceivableSale
539880000
CY2023Q2 us-gaap Accounts Receivable Sale
AccountsReceivableSale
817833000
CY2024Q1 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
425240000
CY2023Q4 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
529266000
CY2024Q1 arw Accounts Receivable Sold Under Factoring Program
AccountsReceivableSoldUnderFactoringProgram
208560000
CY2023Q2 arw Accounts Receivable Sold Under Factoring Program
AccountsReceivableSoldUnderFactoringProgram
382278000
CY2024Q1 arw Other Receivables Sold Under Factoring Program
OtherReceivablesSoldUnderFactoringProgram
259236000
CY2023 arw Other Receivables Sold Under Factoring Program
OtherReceivablesSoldUnderFactoringProgram
375940000
CY2024Q1 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
899400000
CY2023Q4 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
1100000000
CY2024Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
18430000
CY2023Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
32848000
CY2024Q1 us-gaap Debt Current
DebtCurrent
945698000
CY2023Q4 us-gaap Debt Current
DebtCurrent
1653954000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2632250000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2153553000
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
19500000
CY2023Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
14300000
CY2024Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-3600000
CY2023Q2 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
8500000
CY2023Q2 us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
56700000
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
56700000
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1100000000
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1000000000.0
CY2023Q2 us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
10700000
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1563000
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3951000
CY2024Q1 arw Derivative Gain Loss Recognized In Other Comprehensive Income Before Reclassifications Net Of Tax
DerivativeGainLossRecognizedInOtherComprehensiveIncomeBeforeReclassificationsNetOfTax
4970000
CY2023Q2 arw Derivative Gain Loss Recognized In Other Comprehensive Income Before Reclassifications Net Of Tax
DerivativeGainLossRecognizedInOtherComprehensiveIncomeBeforeReclassificationsNetOfTax
-3222000
CY2024Q1 us-gaap Hedged Asset Fair Value Hedge Cumulative Increase Decrease
HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
-400000
CY2023Q2 us-gaap Hedged Asset Fair Value Hedge Cumulative Increase Decrease
HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
-2500000
CY2024Q1 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
200000
CY2023Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
-1700000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
-364000
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
1141000
CY2024Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
47220000
CY2023Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1419000
CY2024Q1 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
46856000
CY2023Q2 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2560000
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
42800000
CY2024Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
32100000
CY2024Q1 arw Number Of Years For Accrual To Be Spent
NumberOfYearsForAccrualToBeSpent
P1Y
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
83601000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
273750000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54251000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58731000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
564000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
748000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54815000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59479000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.66
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.53
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.60
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
128000
CY2024Q1 arw Net Change In Accumulated Other Comprehensive Income Loss
NetChangeInAccumulatedOtherComprehensiveIncomeLoss
-94091000
CY2023Q2 arw Net Change In Accumulated Other Comprehensive Income Loss
NetChangeInAccumulatedOtherComprehensiveIncomeLoss
3794000
CY2024Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1600000000
CY2024Q1 arw Stock Repurchase Program Value Of Shares Repurchased Amount
StockRepurchaseProgramValueOfSharesRepurchasedAmount
1124590000
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
475410000
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
475400000
CY2024Q1 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
47300000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
185917000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
422152000
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
10500000
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
42800000
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 arw Nonrule10b51arrmodified Flag
Nonrule10b51arrmodifiedFlag
false
CY2024Q1 arw Rule10b51arrmodified Flag
Rule10b51arrmodifiedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-006456-index-headers.html Edgar Link pending
0001558370-24-006456-index.html Edgar Link pending
0001558370-24-006456.txt Edgar Link pending
0001558370-24-006456-xbrl.zip Edgar Link pending
arw-20240330.xsd Edgar Link pending
arw-20240330x10q.htm Edgar Link pending
arw-20240330xex10da.htm Edgar Link pending
arw-20240330xex31dia.htm Edgar Link pending
arw-20240330xex31dib.htm Edgar Link pending
arw-20240330xex32di.htm Edgar Link pending
arw-20240330xex32dii.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
arw-20240330_cal.xml Edgar Link unprocessable
arw-20240330_lab.xml Edgar Link unprocessable
arw-20240330_pre.xml Edgar Link unprocessable
arw-20240330x10q_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
arw-20240330_def.xml Edgar Link unprocessable